Live Breaking News & Updates on போர்டியாக்ஸ் பல்கலைக்கழகம் மருத்துவமனை

Stay updated with breaking news from போர்டியாக்ஸ் பல்கலைக்கழகம் மருத்துவமனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Safe Orthopaedics announces CE mark for Sycamore


Safe Orthopaedics announces CE mark for Sycamore
May 24, 2021 02:34 ET
| Source:
Safe Orthopaedics
Safe Orthopaedics
Éragny, FRANCE
 Very dynamic market segment
 Worldwide commercialization expected in 2022
Éragny-sur-Oise, France, On May 24, 2021 à 8:35 CET – Safe Orthopaedics (FR0013467123 – ALSAF), a holding of the Safe Group (composed of Safe Orthopaedics, a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, and Safe Medical (Ex-LCI medical), integrated subcontractor for orthopedic medical devices, today announces the CE mark for Sycamore, a new treatment for the management of patients with one or more osteoporotic fractures.
Osteoporotic fracture is a global clinical issue. Driven by the aging population and the dynamic lifestyle of those 50 years and older, the number of vertebral fractures has increased significantly ....

United States , France General , United Kingdom , Schleswig Holstein , Henri Reynaud , Ardeshir Ardeshiri , Jean Charles Le Huec , Pierre Dumouchel , Safe Group , Bordeaux University Hospital , Safe Orthopaedics , Safe Medical , Bordeaux Nord Aquitaine , Itzehoe Clinic , European Medical Devices Regulation , Paris Stock Exchange Alsaf , Safe Orthopaedics , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , ஸ்சிலேசுவிக் ஹோல்ஸ்டீன் , ஹென்றி றேய்நௌஉத் , பியர் துமௌச்செல் , பாதுகாப்பானது குழு , போர்டியாக்ஸ் பல்கலைக்கழகம் மருத்துவமனை , பாதுகாப்பானது எலும்பியல் ,

Pherecydes Pharma Announces Its 2020 Annual Financial Results and Confirms Its 2021 Outlook


Pherecydes Pharma Announces Its 2020 Annual Financial Results and Confirms Its 2021 Outlook
Regulatory News:
Pherecydes Pharma (FR0011651694 - ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today
announces its annual results for the year to December 31, 2020 and confirms its development prospects for 2021.
Guy-Charles Fanneau de La Horie, Chairman of the Executive Board of Pherecydes Pharma, states: “
Thanks to the resounding success of our Initial Public Offering, we are accelerating the
strategic investments in our R&D and clinical programs. This ramping up is being accompanied by an ongoing very active intellectual property policy that has recently led to the granting of two ....

United States , France General , Hong Kong , Pherecydes Pharma , European Commission , Early Access Program , Research Development , Development Of Phagogram , Bordeaux University Hospital , Programme Hospitalier De Recherche Clinique , Management Committee , Trademark Office , University Hospital , Drug Delivery Congress , European Union , Euronext Growth , United States Patent , Agence Nationale , French National Agency , Annual Inhalation , Respiratory Drug Delivery Congress , Industrial Operations , ஒன்றுபட்டது மாநிலங்களில் , பிரான்ஸ் ஜநரல் , ஹாங் காங் , ஐரோப்பிய தரகு ,

Almost 1 In 3 People In France May Reject COVID-19 Vaccine, Study Finds


Almost one in three working-age adults surveyed in France have said they would refuse any COVID-19 vaccine, according to a new study.
While the findings were gathered back in June 2020 and it’s possible many people have changed their mind since the first wave, the study does highlight how vaccine hesitancy could become a tricky hurdle in the global effort against COVID-19. The research does, however, also show that clearly communicating the benefits of herd immunity can help to persuade those that feel uncertain about vaccines.
In the new study published in The Lancet Public Health researchers from Bordeaux University Hospital, France, and the University of Aberdeen, Scotland asked nearly 2,000 people living in France aged between 18 to 64 years old about their views on the prospect of a COVID-19 vaccine using an online questionnaire completed in June 2020.  ....

United Kingdom , Îe De France , Patrick Peretti Watel , Pierre Verger , European Union , Marseille University , Lancet Public Health , University Of Aberdeen , Bordeaux University Hospital , Observatoire Regional De La Sant , Aix Marseille University , Herd Immunity , Covid 19 , ஒன்றுபட்டது கிஂக்டம் , பியர் வர்‌ஜர் , ஐரோப்பிய தொழிற்சங்கம் , மார்சேய் பல்கலைக்கழகம் , பல்கலைக்கழகம் ஆஃப் குட்டைநாய் வகை , போர்டியாக்ஸ் பல்கலைக்கழகம் மருத்துவமனை , அவதானிப்பு பிராந்திய டி லா சந்த் , ஐஸ் மார்சேய் பல்கலைக்கழகம் , கூட்டம் நோய் எதிர்ப்பு சக்தி ,